Adverse Childhood Experiences in Rural India: Why Western Frameworks Fall Short
The standard Adverse Childhood Experiences framework inadequately captures the spectrum of adversity affecting children in rural India and other low-…
Editor's Top Picks
Maternal RSV Vaccine Cuts Infant Hospitalisation Risk by Half, Real-World Data Show
A nationwide population-based study published in The Lancet ePub shows that maternal RSVpreF vaccination reduces infant RSV hospitalisations by approximately…
Submit Your Paper to GMJ
Digital Twins of Donor Lungs Could Transform Transplant Medicine
Researchers create digital twins of donor lungs using ex vivo perfusion data, enabling virtual testing of therapies and personalized transplant…
Breakthrough Drug Shows 75% Response Rate in Hard-to-Treat Lung Cancer
Sunvozertinib achieved a 75% response rate in previously untreated lung cancer patients with EGFR exon 20 mutations, compared to 25%…
Mirror-image pain after stroke linked to LPA-driven inflammation crossing brain hemispheres
New research reveals that rare bilateral pain after stroke may result from LPA-driven inflammation crossing between brain hemispheres. Understanding this…
Cancer Spreads More in Middle Age Than in Very Old Age, Melanoma Study Shows
New research reveals that melanoma spreads most in middle-aged mice, not elderly ones as expected. Special immune cells that keep…
Teclistamab Shows Strong Response Rates in Earlier-Line Multiple Myeloma Treatment
Phase 3 trial shows teclistamab extends progression-free survival by 7.3 months compared with standard treatments in multiple myeloma patients with…
E-cigarettes deliberately designed to target youth through availability and addictive features, researchers warn
New research reveals how tobacco companies systematically design e-cigarettes to maximize youth appeal, uptake, and dependence through three deliberate strategies.…
FDA’s Pazdur Calls for Agency Restructuring Amid China Competition and Internal Upheaval
FDA's Rick Pazdur calls for fundamental agency restructuring following internal disruption, citing China competition as key driver for reform. Speaking…
Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access
Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations. FDA submission planned as five-year pancreatic cancer survival…